Módszerek összehasonlítása
Tekintse át a kiválasztott módszereket egymás mellett; az eltérő sorok kiemelve jelennek meg.
| Patch-Clamp Elektrofiziológia× | Michaelis-Menten kinetika× | Schild-analízis× | |
|---|---|---|---|
| Tudományterület | Farmakológia | Farmakológia | Farmakológia |
| Módszercsalád | Process / pipeline | Process / pipeline | Process / pipeline |
| Keletkezés éve≠ | 1976 | 1913 | 1947 |
| Megalkotó≠ | Erwin Neher and Bert Sakmann | Leonor Michaelis and Maud Menten | Henry Schild |
| Típus≠ | ion channel screening | mechanistic model | antagonism quantification |
| Alapmű≠ | Neher, E., & Sakmann, B. (1976). Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature, 260(5554), 799-802. DOI ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ | Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Journal of Physiology, 106(3), 337-357. DOI ↗ |
| Alternatív nevek≠ | patch clamp, whole-cell recording, ion channel assay | MM kinetics, Michaelis constant, Vmax | Schild plot, pA2 |
| Kapcsolódó≠ | 3 | 2 | 3 |
| Összefoglaló≠ | Patch-clamp electrophysiology is a technique for measuring ionic currents through ion channels in cell membranes, developed by Neher and Sakmann in 1976. It enables direct observation of single-channel and whole-cell currents at millisecond resolution, making it essential for characterizing drug effects on ion channels and cardiac safety assessment. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. | Schild analysis is a quantitative method for characterizing competitive receptor antagonism developed by Henry Schild in 1947. It uses dose-response curves in the presence and absence of antagonist to estimate the antagonist affinity constant (pA2), enabling standardized comparison of antagonist potency across drugs and experimental systems. |
| ScholarGateAdatkészlet ↗ |
|
|
|